⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EBS News
Emergent Biosolutions, Inc.
EBS SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Emergent BioSolutions Inc. For Possible Securities Law Violations
accessnewswire.com
EBS
Emergent BioSolutions Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Emergent BioSolutions (EBS)
prnewswire.com
EBS
Emergent BioSolutions Inc. (EBS) Securities Fraud Investigation - Levi & Korsinsky
accessnewswire.com
EBS
Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment
globenewswire.com
EBS
Emergent BioSolutions Reports Second Quarter 2026 Financial Results
globenewswire.com
EBS
Form 8-K
sec.gov
EBS
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026
globenewswire.com
EBS
Form 8-K
sec.gov
EBS
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
globenewswire.com
EBS
2026 John Cotton Dana Awards Celebrate 80 Years of Recognizing Excellence in Library Marketing and Communications
prnewswire.com
EBS